Filing Flows › Neuroone Medical Technologies (NMTC) › Q3 FY26 › vs Q3 FY25
Neuroone Medical Technologies (NMTC) Q3 FY26 vs Q3 FY25 (year over year)
Neuroone Medical Technologies's revenue rose $277K (+16%) from $1.7M in Q3 FY25 to $2.0M in Q3 FY26.
Neuroone Medical Technologies, Q3 FY26: revenue $2.0M (+16% year over year), operating margin -122.9%, net loss $2.0M, operating cash flow −$1.1M. The chart draws each line against Q3 FY25, the increases inside each band.
Every line
| Line | Q3 FY26 | Q3 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $2.0M | $1.7M | $277K | +16% |
| Other income, net | $418K | $386K | $32K | +8% |
| Net loss | $2.0M | $1.5M | $505K | +34% |
| Costs & expenses | $4.4M | $3.6M | $815K | +23% |
| Operating costs | $4.4M | $3.6M | $815K | +23% |
| Cost of revenue | $790K | $781K | $9K | +1% |
| Research & development | $1.4M | $1.2M | $243K | +21% |
| SG&A | $2.2M | $1.6M | $563K | +35% |
| Operating cash sources | $2.0M | $1.5M | $505K | +34% |
| Depreciation & amortization | $47K | $67K | −$20K | -29% |
| Share-based compensation | $353K | $317K | $36K | +11% |
| Working capital & other | $525K | −$346K | $871K | — |
| Cash used in operations | $1.1M | $1.5M | −$382K | -26% |
| Net loss absorbed | $2.0M | $1.5M | $505K | +34% |
Questions
How much did Neuroone Medical Technologies's revenue grow year over year in Q3 FY26?
Neuroone Medical Technologies's revenue rose $277K (+16%) from $1.7M in Q3 FY25 to $2.0M in Q3 FY26.